Altria Group Inc. (MO) recently have taken one step ahead with the beta value of 0.68

Altria Group Inc. (NYSE: MO) flaunted slowness of -0.84% at $49.74, before settling in for the price of $50.16 at the close. Taking a more long-term approach, MO posted a 52-week range of $39.06-$54.95.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Consumer Defensive Sector giants’ yearly sales growth during the last 5-year period was 0.91%. Meanwhile, its Annual Earning per share during the time was 4.39%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.08%. This publicly-traded company’s shares outstanding now amounts to $1.76 billion, simultaneously with a float of $1.70 billion. The organization now has a market capitalization sitting at $84.87 billion. At the time of writing, stock’s 50-day Moving Average stood at $51.49, while the 200-day Moving Average is $45.84.

Altria Group Inc. (MO) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Altria Group Inc. industry. Altria Group Inc.’s current insider ownership accounts for 0.14%, in contrast to 59.87% institutional ownership. According to the most recent insider trade that took place on May 02 ’24, this organization’s Sr. VP, Chief HR Off. & CCO sold 22,487 shares at the rate of 43.95, making the entire transaction reach 988,360 in total value, affecting insider ownership by 173,485. Preceding that transaction, on Nov 06 ’23, Company’s Director bought 1,200 for 40.50, making the whole transaction’s value amount to 48,599. This particular insider is now the holder of 8,473 in total.

Altria Group Inc. (MO) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.29 per share during the current fiscal year.

Altria Group Inc.’s EPS increase for this current 12-month fiscal period is 3.08% and is forecasted to reach 5.30 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 4.09% through the next 5 years, which can be compared against the 4.39% growth it accomplished over the previous five years trading on the market.

Altria Group Inc. (NYSE: MO) Trading Performance Indicators

Let’s observe the current performance indicators for Altria Group Inc. (MO). It’s Quick Ratio in the last reported quarter now stands at 0.30. The Stock has managed to achieve an average true range (ATR) of 0.67. Alongside those numbers, its PE Ratio stands at $8.58, and its Beta score is 0.68. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.18. Similarly, its price to free cash flow for trailing twelve months is now 9.62.

In the same vein, MO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 5.80, a figure that is expected to reach 1.35 in the next quarter, and analysts are predicting that it will be 5.30 at the market close of one year from today.

Technical Analysis of Altria Group Inc. (MO)

Now, what If we examine the latest scores posted by [Altria Group Inc., MO]. During the last 5-days, its volume was lower the volume of 9.98 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 42.84% While, its Average True Range was 0.65.

Raw Stochastic average of Altria Group Inc. (MO) in the period of the previous 100 days is set at 53.15%, which indicates a major rise in contrast to 20.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 10.65% that was lower than 16.73% volatility it exhibited in the past 100-days period.